leftspacer middlespacer rightspacer
Media Menu
Featured Material

MAPS Bulletin Summer 2014: Research Edition
Media > Recent and Archival
December 3, 2012

Ecstasy Used to Treat PTSD Patients Sees Success

By: Alexander Besant

Global Post

Global Post explores the results and presents the facts from research into treating posttraumatic stress disorder (PTSD) with MDMA-assisted psychotherapy.

Originally appearing here.

Ecstasy may be used to help Post-Traumatic Stress Disorder (PTSD) patients.

Researchers in South Carolina found that the purer form of Ecstasy, MDMA, can help treat the mental illness if it is coupled with psychotherapy.

CNN reportedthat the small study looked at 19 people with PTSD.

Using psychotherapy in combination with the MDMA showed that 14 out of 19 patients saw benefits.

“With such encouraging data, including evidence of long-term effectiveness after only two or three MDMA-assisted psychotherapy sessions, there is now no doubt that this research should be expanded to larger clinical trials,” said study author Michael Mithoefer, according to the Daily Mail.

The research group reported that they are now testing the drug-therapy combination on 24 first-responders and military veterans to better understand why MDMA seems to be so effective.

Military suicides in the US are at a 30-year high due to the trauma from wars in Iraq and Afghanistan.

It is believed that 1 in 7 Iraq and Afghanistan veterans suffer from PTSD.

The research is being undertaken by “MAPS,” the Multidisciplinary Association of Psychedelic Studies.

It is the only organization in the world funding clinical trials of MDMA-based psychotherapy

The study was published last month in the Journal of Psychopharmacology.

Back to MAPS in the Media

Give Our Veterans Hope
1 in 7 Iraq and Afghanistan veterans suffer from PTSD, in many cases leading to suicide. We owe it to our veterans to stop this epidemic.

Tell the Pentagon to fund MAPS' groundbreaking work to treat PTSD.